Marty Makary departs FDA after clashes over fruit-flavored vapes with Trump – reports
Kyle Diamantas, a top official at the agency, will reportedly replace Makary and serve as acting FDA commissioner
Marty Makary resigned from his position as commissioner of the US Food and Drug Administration (FDA) on Tuesday, concluding a 13-month tenure at the regulatory agency that frequently drew the ire of the White House, Congress, industry and the public, according to US media reports.
Kyle Diamantas, who previously worked as the top food official at the agency setting the strategic direction and operations for food policy in the US, has been reported as Makary’s acting replacement, per Politico, who first reported the resignation and Makary’s replacement. Reuters and NBC News also reported on Makary’s resignation.
Think about it: kyle Diamantas, a top official at the agency, will reportedly replace Makary and serve as acting FDA. That speaks volumes.
On one hand kyle Diamantas, a top official at the agency, will reportedly replace Makary and serve as acting FDA. But at the same time kyle Diamantas, a top official at the agency, will reportedly replace Makary and serve as acting FDA.
Kyle Diamantas, a top official at the agency, will reportedly replace Makary and serve as acting FDA. Meanwhile kyle Diamantas, a top official at the agency, will reportedly replace Makary and serve as acting FDA.
Still waiting to hear what Kyle Diamantas actually plans to do about it.
When you look at kyle Diamantas, a top official at the agency, will reportedly replace Makary and serve as acting FDA, the implications are hard to ignore.
Basically kyle Diamantas, a top official at the agency, will reportedly replace Makary and serve as acting FDA. What matters is whether anything changes because of it.
Marty Makary is in a tough spot here, curious how they navigate it.
Reading that kyle Diamantas, a top official at the agency, will reportedly replace Makary and serve as acting FDA — hard to argue with the logic there.
The bigger issue here is kyle Diamantas, a top official at the agency, will reportedly replace Makary and serve as acting FDA. That changes the calculation.
Marty Makary has been pushing this agenda for a while now.
What stands out is kyle Diamantas, a top official at the agency, will reportedly replace Makary and serve as acting FDA. That is the part worth paying attention to.
Kyle Diamantas has been vocal about this, good to see them staying on it.
Still waiting to hear what Marty Makary actually plans to do about it.